Oppenheimer raised the firm’s price target on Itron (ITRI) to $155 from $150 and keeps an Outperform rating on the shares. The firm notes shares were down hsd Thursday after Itron beat and raised EPS above consensus while trimming revenue guidance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
- Itron price target lowered to $129 from $137 at Baird
- Itron Inc. Reports Strong Q2 2025 Financial Results
- Itron’s Strong Financial Performance and Growth Potential: A Buy Rating Despite Short-term Challenges
- JPMorgan upgrades Itron to Overweight, says ‘buy the dip’
- Itron upgraded to Overweight from Neutral at JPMorgan